Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and managementCapsule Summary

• Autores principales: Michela Starace, PhD (Autor), Matilde Iorizzo, PhD (Autor), Andrea Sechi, MD (Autor), Aurora Maria Alessandrini, MD (Autor), Miriam Carpanese, MD (Autor), Francesca Bruni, MD (Autor), Giulio Vara, MD (Autor), Zoe Apalla, MD (Autor), Daniel Asz-Sigall, MD (Autor), Stefania Barruscotti, MD (Autor), Francisco Camacho, PhD (Autor), Isabella Doche, PhD (Autor), Bruna Duque Estrada, MD (Autor), Rachita Dhurat, MD (Autor), Maria Fernanda Gavazzoni, MD (Autor), Ramon Grimalt, PhD (Autor), Matthew Harries, MD (Autor), Dimitrios Ioannidis, MD (Autor), Amy McMichael, MD (Autor), Daniel Fernandes Melo, PhD (Autor), Rui Oliveira, MD (Autor), Yuliya Ovcharenko, MD (Autor), Rodrigo Pirmez, PhD (Autor), Yuval Ramot, PhD (Autor), Lidia Rudnicka, PhD (Autor), Jerry Shapiro, PhD (Autor), Tatiana Silyuk, MD (Autor), Rodney Sinclair, PhD (Autor), Antonella Tosti, PhD (Autor), Sergio Vano-Galvan, PhD (Autor), Bianca Maria Piraccini, PhD (Autor)
• Formato: Libro
• Publicado: Elsevier, 2021-12-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background: The cutaneous manifestations of COVID-19 may be useful disease markers and prognostic indicators. Recently, postinfectious telogen effluvium and trichodynia have also been reported. Objective: To evaluate the presence of trichodynia and telogen effluvium in patients with COVID-19 and des...